Alpha Tau Medical (DRTS) Consolidated Net Income (2021 - 2026)

Alpha Tau Medical (DRTS) has 6 years of Consolidated Net Income data on file, last reported at $22.9 million in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income rose 166.98% year-over-year to $22.9 million; the trailing twelve-month figure through Mar 2026 stood at $56.8 million (up 75.67% YoY), and the FY2025 full-year result was $42.4 million, up 33.55% from the prior year.
• Consolidated Net Income improved to $22.9 million in Q1 2026, from $12.2 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $25.7 million in Q1 2022 to a low of $2.0 million in Q2 2022.
• A 5-year average of $9.4 million and a median of $8.1 million in 2023 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income tumbled 71.42% in 2022 and jumped 334.88% in 2023, its largest moves.
• Tracing DRTS's Consolidated Net Income over 5 years: stood at $3.4 million in 2022, then soared by 116.78% to $7.3 million in 2023, then increased by 28.89% to $9.5 million in 2024, then increased by 28.86% to $12.2 million in 2025, then soared by 87.93% to $22.9 million in 2026.
• Business Quant data shows DRTS's Consolidated Net Income at $22.9 million in Q1 2026, $12.2 million in Q4 2025, and $11.7 million in Q3 2025.